Drug Shortage Report for CYANOKIT
Report ID | 44171 |
Drug Identification Number | 02375370 |
Brand name | CYANOKIT |
Common or Proper name | Hydroxocobalamin Powder for Infusion |
Company Name | SERB S.A. |
Market Status | MARKETED |
Active Ingredient(s) | HYDROXOCOBALAMIN |
Strength(s) | 5G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5 g / vial |
ATC code | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-03-27 |
Estimated end date | 2018-06-08 |
Actual end date | 2018-06-07 |
Shortage status | Resolved |
Updated date | 2018-06-08 |
Company comments | Please note that product is in transit and we are expecting to fill backorders by Friday June 8, 2018. For more information, please contact Methapharm Inc. at 1-800-287-7686, sales@methapharm.com, or by fax at 1-519-751-9149. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 480 AVENUE LOUISE BRUSSELS, BRUSSELS CAPITAL REGION BELGIUM 1050 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v23 | 2018-06-08 | English | Compare |
v22 | 2018-06-07 | French | Compare |
v21 | 2018-06-07 | English | Compare |
v20 | 2018-06-07 | English | Compare |
v19 | 2018-06-04 | French | Compare |
v18 | 2018-06-04 | English | Compare |
v17 | 2018-05-02 | French | Compare |
v16 | 2018-05-02 | English | Compare |
v15 | 2018-05-02 | English | Compare |
v14 | 2018-04-18 | French | Compare |
v13 | 2018-04-18 | English | Compare |
v12 | 2018-04-18 | French | Compare |
v11 | 2018-04-18 | English | Compare |
v10 | 2018-03-28 | French | Compare |
v9 | 2018-03-28 | French | Compare |
v8 | 2018-03-28 | English | Compare |
v7 | 2018-03-28 | English | Compare |
v6 | 2018-03-28 | English | Compare |
v5 | 2018-03-28 | French | Compare |
v4 | 2018-03-28 | English | Compare |